NJ State Employees Deferred Compensation Plan’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-110,000
| Closed | -$568K | – | 565 |
|
|
2019
Q2 | $568K | Buy |
110,000
+40,000
| +57% | +$207K | 0.1% | 206 |
|
|
2019
Q1 | $252K | Buy |
70,000
+40,000
| +133% | +$144K | 0.05% | 473 |
|
|
2018
Q4 | $184K | Sell |
30,000
-145,000
| -83% | -$889K | 0.04% | 472 |
|
|
2018
Q3 | $1.02M | Sell |
175,000
-5,000
| -3% | -$29.2K | 0.17% | 129 |
|
|
2018
Q2 | $765K | Buy |
180,000
+10,000
| +6% | +$42.5K | 0.14% | 188 |
|
|
2018
Q1 | $750K | Buy |
170,000
+30,000
| +21% | +$132K | 0.13% | 215 |
|
|
2017
Q4 | $736K | Buy |
+140,000
| New | +$736K | 0.13% | 236 |
|